Cannabidiol (CBD) for the treatment of bipolar affective disorder (2007)
- Autores:
- Autores USP: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; QUEIROZ, REGINA HELENA COSTA - FCFRP ; ZUARDI, ANTONIO WALDO - FMRP
- Unidades: FMRP; FCFRP
- Assuntos: TRANSTORNO BIPOLAR; CANNABIS
- Idioma: Inglês
- Imprenta:
- Editora: International Cannabinoid Research Society
- Local: Québec
- Data de publicação: 2007
- Fonte:
- Título do periódico: Program and Abstracts
- Nome do evento: Annual Symposium on the Cannabinoids
-
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabidiol (CBD) for the treatment of bipolar affective disorder. 2007, Anais.. Québec: International Cannabinoid Research Society, 2007. . Acesso em: 18 abr. 2024. -
APA
Crippa, J. A. de S., Hallak, J. E. C., Vilela, J. A. A., Morais, S. L., Sanches, R. F., Malfará, W., et al. (2007). Cannabidiol (CBD) for the treatment of bipolar affective disorder. In Program and Abstracts. Québec: International Cannabinoid Research Society. -
NLM
Crippa JA de S, Hallak JEC, Vilela JAA, Morais SL, Sanches RF, Malfará W, Camargo SPS, Musty RE, Queiroz RHC, Zuardi AW. Cannabidiol (CBD) for the treatment of bipolar affective disorder. Program and Abstracts. 2007 ;[citado 2024 abr. 18 ] -
Vancouver
Crippa JA de S, Hallak JEC, Vilela JAA, Morais SL, Sanches RF, Malfará W, Camargo SPS, Musty RE, Queiroz RHC, Zuardi AW. Cannabidiol (CBD) for the treatment of bipolar affective disorder. Program and Abstracts. 2007 ;[citado 2024 abr. 18 ] - Safety and side effects of cannabidiol, a Cannabis sativa constituent
- Cannabidiol: an anxiolytic or an antipsychotic new drug?
- Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update
- Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
- Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
